OPGX - NEWS $$$$ Optigenex Inc. Agrees to Long-Term License

6 Kommentare / 0 neu
04.01.2010 17:40
#1
Bild des Benutzers JohnJohnson
Offline
Kommentare: 75
OPGX - NEWS $$$$ Optigenex Inc. Agrees to Long-Term License

Optigenex Inc. Agrees to Long-Term License Granting Promethean Corporation Exclusive North American Distribution Rights for Cosm

NEW YORK, NY -- (Marketwire) -- 01/04/10 --

Optigenex Inc. (PINKSHEETS: OPGX) announced today the signing of a long term exclusive license agreement with Promethean Corporation for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11®, a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors

Under the new agreement, Promethean through its wholly owned subsidiary, Ceres Living will market the "AIO Premium Cellular Health(TM)" line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11®. The contract vests Promethean with exclusivity in the North American "Direct Sales" or "Network Marketing" distribution channel coinciding with the expiration of similar channel rights previously held by former licensee. In addition to North American Direct Sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia

Daniel Zwiren, president and CEO of Optigenex Inc. said, "Teaming up with Promethean promises to be the perfect start of a new decade for Optigenex

The management at Promethean and its wholly owned subsidiary, Ceres Living are professionals with a proven record in business management and the Direct Sales (Network Marketing) distribution channel. We are excited to see the AC-11® brand and our unique theme of DNA health associated with the innovative technologies behind AIO Premium Cellular Health(TM)."

Matthew Henninger, Chairman & CEO of Promethean Corporation, added, "We had wanted to work with the Optigenex team and their product AC-11® since before we developed the AIO Premium Cellular Health(TM) product line. Now that timing has allowed our two companies to align, we look forward to continued collaborative research and development of products that offer the best technologies in cellular health and nutrition."

About Optigenex Inc.:

Optigenex Inc. is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. AC-11® (formerly known as C-MED-100®) is the company's patented all-natural extract from the medicinal herb Uncaria tomentosa. From its origins in the Amazon Rain Forest, AC-11® delivers a unique bioactive compound of water soluble carboxy alkyl esters (CAEs(TM)) that form the backbone of the company's revolutionary approach to DNA care and healthy aging. For more information about Optigenex please visit our website: www.optigenex.com

About Promethean Corporation:

Promethean Corp. ("Promethean") is a New York City based Health Care related products and services company that develops, manufactures and distributes its own products. The company through its wholly owned subsidiary, Ceres Living produces and sells the AIO Premium Cellular Health(TM) product line. The company develops Advanced Nutraceuticals, Advanced Personal Care products and other Nutritional and Wellness Products and Services that it plans to sell in multiple channels of distribution

For more information about Promethean Corporation, please contact the company at (212)-355-5129

*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to treat, diagnose, cure or prevent any disease

Contact: Optigenex Inc

Dan Zwiren president and CEO Optigenex Inc

dzwiren@optigenex.com 201 355 2098

Aufklappen
06.01.2010 18:40
Bild des Benutzers Prise Salz
Offline
Kommentare: 2347
OPGX - NEWS $$$$ Optigenex Inc. Agrees to Long-Term License

*boah*

Soeben sind 1.5 MIO. Aktien über den Tisch, da wird so richtig mit der grossen Kelle gemischt! *staun*

(umgerechnet sinds aber immer noch NUR 450 Döllis!)

:oops: :oops: *sorry*

06.01.2010 15:42
Bild des Benutzers Dr.Zock
Offline
Kommentare: 5617
OPGX - NEWS $$$$ Optigenex Inc. Agrees to Long-Term License

@ JohnJohnson

Sag mal was rauchst Du denn ?

...Und bevor ichs vergesse, denk daran, die Rolle des Forumsclowns wird bereits von mir besetzt. :lol::lol::lol::lol:

Mich von diesem Thron zu stossen haben schon ander vor Dir versucht.

Deine Postings sind also zwecklos.

Gruss

Dr.Zock

Es ist leichter, einer Begierde ganz zu entsagen, als in ihr maßzuhalten. ( Friedrich Nietzsche )

06.01.2010 15:17
Bild des Benutzers JohnJohnson
Offline
Kommentare: 75
Pinnacle Digest: Looking For Shareholder Opinions On Optigen

Pinnacle Digest: Looking For Shareholder Opinions On Optigenex's Latest Agreement With Promethean Corporation

Jan 05, 2010 (M2 PRESSWIRE via COMTEX) -- www.PinnacleDigest.com is a performance-driven online financial magazine and social network with a proven track record. After yesterday's news from Optigenex Inc. (PINKSHEETS: OPGX) announcing the signing of a long term exclusive license agreement with Promethean Corporation for distribution and marketing of branded cosmeceutical and dietary supplement products, our team is inviting all shareholders to their exclusive investor controlled forum. Our staff and members have requested that all Optigenex shareholders join our community and share their thoughts on the company, its development and future outlook. One of the most important aspects when we research for new investments is to understand the sentiment of the current shareholders; that is why we have released this announcement - we want to know your opinion.

Join The Optigenex Investor Discussion Here: http://www.pinnacledigest.com/company/opgx

Join PinnacleDigest.com to

Find out if Optigenex makes it as a Pinnacle Featured Company,

Chat with other shareholders invested in Optigenex,

Explain to our investor community what differentiates this company,

Connect with investors and professionals in the equity markets,

Meet the thousands of investors who have already become members of the Pinnacle community.

PinnacleDigest.com is an investment club comprised of over 15,000 members. We use all of our member's insight when selecting our next investment opportunity. Your membership is free - join today.

PinnacleDigest.com has no vested interest in the company mentioned herein. The company mentioned in this release has not compensated PinnacleDigest.com in any form to disseminate this release.

This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.

CONTACT: Pinnacle Digest WWW: http://www.pinnacledigest.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

(C)1994-2010 M2 COMMUNICATIONS

05.01.2010 20:37
Bild des Benutzers JohnJohnson
Offline
Kommentare: 75
NEWS $$$$ Optigenex signs license agreement with Promethean

NEWS $$$$ Optigenex signs license agreement with Promethean for AIO Premium cellular health in China

13 minutes ago - Datamonitor Financial Deals Tracker

Optigenex, Inc. has singed a long term exclusive license agreement with Promethean Corporation, a developer of healthcare products and services, for the distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11(R) in China. Optigenex is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. Both the partners are based in the US.

AC-11(R) is a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors.

Under the new agreement, Promethean through its wholly-owned subsidiary, Ceres Living will market the 'AIO Premium Cellular Health(TM)' line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11(R). The contract vests Promethean with exclusivity in the North American direct sales or network marketing distribution channel coinciding with the expiration of similar channel rights previously held by former licensee.

In addition to North American direct sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.

Deal Type Partnership

Sub-Category Acquisition of Rights,Marketing,Sales,Distribution

Deal Status Announced: 2010-01-04

Deal Participants

Partner 1 (Company) Ceres Living, Inc.

Partner 2 (Company) Optigenex, Inc.

Partner 3 (Company) Promethean Corporation

05.01.2010 12:20
Bild des Benutzers JohnJohnson
Offline
Kommentare: 75
Go OPGX..link to new product here!

Go OPGX..link to new product here!

http://www.stemcellhealthtoday.com